Cost-Effectiveness of the Self-Care Management System for Heart Failure
- PMID: 39802132
- PMCID: PMC11711784
- DOI: 10.1253/circrep.CR-24-0088
Cost-Effectiveness of the Self-Care Management System for Heart Failure
Abstract
Background: We recently reported that the self-care management system for heart failure (HF) decreased re-hospitalization for HF. In the present study we estimate the cost-effectiveness of this system.
Methods and results: We retrospectively enrolled 569 consecutive patients who were admitted for HF treatment at Kitano Hospital. In the present analysis, we sought to compare cardiovascular healthcare costs and the incremental cost-effective ratio (ICER), expressed as the cost per quality-adjusted life-years (QALY) gained, between patients using the self-care management system (n=153) and those not using the system (n=153) after propensity-score matching. To calculate the QALY, we used the New York Heart Association class and the corresponding scores of quality of life in every 3 months. The healthcare costs of cardiovascular disease were ¥129,747,016 in the user group and ¥156,427,032 in the non-user group, where 24 and 43 patients were hospitalized, respectively. The cost of this new system was ¥50,000 in the user group. The total costs were ¥129,797,016 in the user group and ¥156,427,032 in the non-user group. By using the system, the QALY increased from 0.653 to 0.686. The ICER was below 0 and the system was interpreted as cost-effective.
Conclusions: Use of the self-care management system is likely to be a cost-effective treatment for HF with the increase in QALY and the decrease in healthcare costs.
Keywords: Cost-effectiveness; Heart failure; Rehospitalization; Self-care management.
Copyright © 2025, THE JAPANESE CIRCULATION SOCIETY.
Conflict of interest statement
E.N., M. Inoko, H.F., M.Y., Y. Yamaji, and T. Hamaguchi received a research grant from Bayer Yakuhin, Ltd, Takeda Pharmaceutical CO., Ltd, Novartis Pharma K.K., and IQVIA Services Japan G.K., and a scholarship grant from IQVIA Services Japan G.K., and Research Institute of Production Development. The other authors have no conflicts of interest.
Figures
References
-
- Soundarraj D, Singh V, Satija V, Thakur RK.. Containing the cost of heart failure management: A focus on reducing readmissions. Heart Failure Clin 2017; 13: 21–28. - PubMed
-
- Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al.. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489–491. - PubMed
-
- Kanaoka K, Okayama S, Nakai M, Sumita Y, Nishimura K, Kawakami R, et al.. Hospitalization costs for patients with acute congestive heart failure in Japan. Circ J 2019; 83: 1025–1031. - PubMed
-
- Nakane E, Kato T, Tanaka N, Kuriyama T, Kimura K, Nishiwaki S, et al.. Association of the induction of a self-care management system with 1-year outcomes in patients hospitalized for heart failure. J Cardiol 2021; 77: 48–56. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
